Market Outlook
The global Organoid Biobank market size was valued at USD 124.5 million in 2022 and is forecast to a readjusted size of USD 389.7 million by 2029 with a CAGR of 17.7% during review period.
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Report includes an overview of the development of the Organoid Biobank industry chain, the market status of Biopharmaceutical Companies (Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids), Contract Research Organizations (Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Organoid Biobank.
Regionally, the report analyzes the Organoid Biobank markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Organoid Biobank market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Organoid Biobank market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Organoid Biobank industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Organoid Biobank market.
Regional Analysis: The report involves examining the Organoid Biobank market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Organoid Biobank market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Organoid Biobank:
Company Analysis: Report covers individual Organoid Biobank players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Organoid Biobank This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biopharmaceutical Companies, Contract Research Organizations).
Technology Analysis: Report covers specific technologies relevant to Organoid Biobank. It assesses the current state, advancements, and potential future developments in Organoid Biobank areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Organoid Biobank market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Key Market Players
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Segmentation By Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Segmentation By Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Organoid Biobank Market in 2025?
The Organoid Biobank Market in 2025 is likely to benefit from advancements in stem cell technology, enabling the development of more accurate and diverse organoid models. These models will significantly enhance drug discovery, disease modeling, and personalized medicine, offering high precision and better representation of human biology. Furthermore, increasing collaborations between biotech companies and research institutions will drive innovation and adoption.
What are the weaknesses of the Organoid Biobank Market in 2025?
A key weakness of the Organoid Biobank Market is the complexity and high costs associated with maintaining large-scale biobanks. Additionally, organoid models may still lack full functionality in comparison to real human organs, limiting their effectiveness in certain research applications. The market may also face regulatory hurdles and ethical concerns related to stem cell use and genetic modifications.
What opportunities exist for the Organoid Biobank Market in 2025?
The growing demand for precision medicine and the continuous progress in regenerative medicine create significant opportunities for the Organoid Biobank Market. With an increasing focus on tailored therapies, organoid models can serve as powerful tools for drug testing, genetic research, and disease prevention. Furthermore, expanding the biobank to include diverse populations can address current gaps in representation and improve global healthcare outcomes.
What are the threats to the Organoid Biobank Market in 2025?
The Organoid Biobank Market faces threats from competing technologies such as microfluidics and computational modeling, which could reduce the need for physical organoid samples. Moreover, intellectual property issues and the possibility of data breaches in biobanks could hinder market growth. Finally, fluctuations in regulatory environments and funding restrictions for stem cell research could impede the development and scalability of organoid biobanks.
Market PESTEL Analysis
What political factors could impact the organoid biobank market in 2025?
Government regulations on biobanking, ethical considerations for organoid research, and funding policies for regenerative medicine will play a key role. International collaborations may be influenced by geopolitical tensions and data-sharing agreements.
What economic factors will shape the organoid biobank industry?
Investment in biotech startups, healthcare budget allocations, and the cost-effectiveness of organoid-based drug testing will drive market growth. Economic slowdowns or recessions could limit funding for research and development.
How will social factors influence the adoption of organoid biobanks?
Public perception of organoid technology, ethical concerns about tissue donation, and increasing demand for personalized medicine will impact market acceptance. Growing awareness of organoid-based drug testing could accelerate adoption.
What technological advancements will drive the organoid biobank market?
Innovations in 3D bioprinting, automation in organoid culturing, and AI-driven analytics for biobank data will enhance efficiency and scalability. Advances in cryopreservation techniques will improve long-term storage and viability.
How will environmental factors affect the organoid biobank sector?
Sustainability concerns in lab operations, energy-intensive storage solutions, and bio-waste management regulations could shape industry practices. The push for eco-friendly biobanking solutions may drive innovations in green lab technologies.
What legal challenges could impact the growth of organoid biobanks?
Intellectual property rights on organoid models, patient consent for tissue donation, and compliance with evolving biobank regulations will be critical. Differences in global legal frameworks could pose challenges for cross-border research and commercialization.
Market SIPOC Analysis
Who are the key suppliers in the organoid biobank market?
Tissue donors, biotechnology companies, research institutions, and reagent suppliers provide the essential raw materials. This includes biological samples, growth factors, culture media, cryopreservation agents, and specialized lab equipment. Regulatory bodies also play a role by supplying guidelines and approvals needed for legal and ethical compliance.
What inputs are required for an organoid biobank?
High-quality tissue samples from diverse donors, advanced cell culture technology, state-of-the-art bioreactors, automated cryopreservation systems, and AI-driven data management infrastructure are essential. Additionally, regulatory approvals, funding, and trained personnel ensure smooth operations and compliance with ethical standards.
What are the main processes involved in an organoid biobank?
Tissue procurement from donors or patients, organoid culturing under controlled conditions, continuous monitoring for quality assurance, data annotation for traceability, and cryopreservation for long-term storage are key steps. Ethical approvals, licensing, and periodic validation of organoid models further support reliability and compliance with research and clinical applications.
What outputs does an organoid biobank generate?
Organoid biobanks produce well-characterized, viable organoid samples, detailed biological datasets, and validated disease models. These outputs contribute to drug discovery, personalized medicine, toxicology screening, and regenerative therapies. Additionally, biobanks generate research reports, intellectual property, and scientific publications that help advance medical knowledge.
Who are the primary customers of organoid biobanks?
Pharmaceutical companies use organoid biobanks for drug screening and preclinical trials. Biotech firms leverage them for innovation in regenerative medicine and precision therapies. Academic researchers and contract research organizations (CROs) depend on organoids for studying disease mechanisms. Healthcare institutions and diagnostic labs also benefit from these biobanks for testing patient-specific treatment responses. Regulatory agencies may engage with biobanks for standardization and quality benchmarking in biomedical research.
Market Porter's Five Forces
How intense is the competitive rivalry in the organoid biobank market?
The market is moderately competitive, with a mix of established biotech firms, academic institutions, and emerging startups. Competition is driven by innovation in organoid culturing, data analytics, and storage techniques. However, high entry barriers and regulatory constraints limit the number of direct competitors.
What is the threat of new entrants in the organoid biobank market?
The threat of new entrants is relatively low due to the high costs of setting up advanced biobanking infrastructure, regulatory approval challenges, and the need for specialized expertise. However, breakthroughs in automation and AI-driven biobanking could lower entry barriers in the future.
How strong is the bargaining power of suppliers?
Suppliers of tissue samples, reagents, and cryopreservation technologies hold significant bargaining power, as high-quality materials and proprietary growth factors are crucial for organoid viability. Limited availability of ethically sourced donor tissues further strengthens supplier influence.
What is the bargaining power of buyers in the organoid biobank industry?
Pharmaceutical companies, biotech firms, and research institutions have moderate bargaining power. While demand for organoids is rising, the limited number of high-quality biobanks restricts buyers’ choices. Customization options and exclusive research collaborations can give buyers some leverage.
How significant is the threat of substitutes for organoid biobanks?
The threat of substitutes is low, as organoid-based models offer unique advantages over traditional 2D cell cultures and animal testing. However, alternative technologies like organ-on-a-chip and AI-driven in silico modeling could pose a partial substitute for specific applications.
Market Upstream Analysis
What are the key upstream components of the organoid biobank market?
The upstream segment includes tissue donors, biotechnology firms supplying growth factors and culture media, manufacturers of lab equipment, and AI-driven data management providers. Regulatory bodies also play a role in approving and standardizing biobanking processes.
How important are tissue donors in the organoid biobank supply chain?
Tissue donors are critical, as high-quality human samples form the foundation of organoid biobanking. Ethical sourcing, donor consent, and regulatory compliance are essential to ensure a steady and legally approved supply of biological materials.
What role do biotechnology companies play in the upstream process?
Biotech companies supply essential reagents, including extracellular matrices, specialized culture media, and cryopreservation solutions. Their innovations in 3D cell growth and bioprinting technologies enhance the scalability and efficiency of organoid production.
How does lab equipment impact organoid biobanking?
Advanced lab equipment such as bioreactors, automated imaging systems, and cryogenic storage units enable precise organoid culturing, monitoring, and long-term preservation. Reliable equipment ensures consistency and reproducibility in organoid-based research.
What regulatory factors influence the upstream organoid biobank market?
Strict regulations govern tissue procurement, data privacy, and quality control in biobanking. Compliance with international standards, such as Good Manufacturing Practice (GMP) and ethical guidelines for human tissue use, is essential for legal and commercial viability.
Market Midstream Analysis
Who are the key players in the midstream segment of the organoid biobank market?
Organoid biobank operators, research institutions, contract research organizations (CROs), and pharmaceutical companies play central roles. These entities handle organoid cultivation, quality control, data management, and sample distribution for research and clinical applications.
What processes are involved in the midstream phase of organoid biobanking?
The midstream phase includes organoid culturing, expansion, characterization, and validation. Quality assurance through imaging, genetic profiling, and functional testing ensures reliability before storage or distribution. Ethical compliance and data annotation are also key steps.
How is organoid storage managed in the midstream segment?
Cryopreservation techniques, including ultra-low temperature storage and vitrification, are used to maintain organoid viability. Automated biorepositories with controlled environmental conditions ensure long-term stability and accessibility.
What role does data management play in organoid biobanking?
AI-driven platforms and cloud-based databases store organoid metadata, donor information, and experimental results. Standardized data formats improve traceability, facilitate collaborations, and enhance the reproducibility of research findings.
How do regulatory and ethical considerations impact the midstream process?
Strict guidelines govern organoid handling, ensuring ethical tissue use, patient consent, and compliance with international standards. Continuous audits and certifications help maintain credibility and facilitate cross-border research collaborations.
Market Downstream Analysis
Who are the key downstream users of organoid biobanks?
Pharmaceutical companies, biotech firms, academic researchers, contract research organizations (CROs), and healthcare institutions rely on organoid biobanks for drug discovery, disease modeling, and personalized medicine applications.
How are organoids used in pharmaceutical and biotech industries?
Organoids are employed in high-throughput drug screening, toxicity testing, and precision medicine development. They help reduce reliance on animal models and improve the prediction of human responses to new treatments.
What role do academic and clinical researchers play in the downstream market?
Researchers use organoid biobanks to study disease mechanisms, genetic disorders, and patient-specific treatment responses. Organoid-based studies contribute to regenerative medicine, oncology research, and neurology advancements.
How does organoid biobanking support personalized medicine?
By preserving patient-derived organoids, biobanks enable tailored drug testing and treatment selection. This approach enhances the effectiveness of therapies while minimizing adverse effects, especially in oncology and rare disease treatments.
What are the commercial and regulatory challenges in the downstream segment?
High costs of organoid-based research, data-sharing complexities, and varying global regulations pose challenges. Standardization efforts and collaborative frameworks are essential for ensuring ethical use and widespread clinical adoption.
Chapter 1, to describe Organoid Biobank product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Organoid Biobank, with revenue, gross margin and global market share of Organoid Biobank from 2018 to 2023.
Chapter 3, the Organoid Biobank competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Organoid Biobank market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Organoid Biobank.
Chapter 13, to describe Organoid Biobank research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Organoid Biobank
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Organoid Biobank by Type
1.3.1 Overview: Global Organoid Biobank Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Organoid Biobank Consumption Value Market Share by Type in 2022
1.3.3 Tissue Derived Organoids
1.3.4 Pluripotent Stem Cell-derived Organoids
1.4 Global Organoid Biobank Market by Application
1.4.1 Overview: Global Organoid Biobank Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Biopharmaceutical Companies
1.4.3 Contract Research Organizations
1.4.4 Academics and Research Institutes
1.5 Global Organoid Biobank Market Size & Forecast
1.6 Global Organoid Biobank Market Size and Forecast by Region
1.6.1 Global Organoid Biobank Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Organoid Biobank Market Size by Region, (2018-2029)
1.6.3 North America Organoid Biobank Market Size and Prospect (2018-2029)
1.6.4 Europe Organoid Biobank Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Organoid Biobank Market Size and Prospect (2018-2029)
1.6.6 South America Organoid Biobank Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Organoid Biobank Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 FRANKFURT CANCER INSTITUTE
2.1.1 FRANKFURT CANCER INSTITUTE Details
2.1.2 FRANKFURT CANCER INSTITUTE Major Business
2.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Product and Solutions
2.1.4 FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 FRANKFURT CANCER INSTITUTE Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Organoid Biobank Product and Solutions
2.2.4 Merck Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments and Future Plans
2.3 Crown Bioscience
2.3.1 Crown Bioscience Details
2.3.2 Crown Bioscience Major Business
2.3.3 Crown Bioscience Organoid Biobank Product and Solutions
2.3.4 Crown Bioscience Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Crown Bioscience Recent Developments and Future Plans
2.4 HUB Organoids
2.4.1 HUB Organoids Details
2.4.2 HUB Organoids Major Business
2.4.3 HUB Organoids Organoid Biobank Product and Solutions
2.4.4 HUB Organoids Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 HUB Organoids Recent Developments and Future Plans
2.5 Cancer Research UK Convergence Science Centre
2.5.1 Cancer Research UK Convergence Science Centre Details
2.5.2 Cancer Research UK Convergence Science Centre Major Business
2.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Product and Solutions
2.5.4 Cancer Research UK Convergence Science Centre Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cancer Research UK Convergence Science Centre Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business
2.6.3 Thermo Fisher Scientific Organoid Biobank Product and Solutions
2.6.4 Thermo Fisher Scientific Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Corning
2.7.1 Corning Details
2.7.2 Corning Major Business
2.7.3 Corning Organoid Biobank Product and Solutions
2.7.4 Corning Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Corning Recent Developments and Future Plans
2.8 STEMCELL Technologies
2.8.1 STEMCELL Technologies Details
2.8.2 STEMCELL Technologies Major Business
2.8.3 STEMCELL Technologies Organoid Biobank Product and Solutions
2.8.4 STEMCELL Technologies Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 STEMCELL Technologies Recent Developments and Future Plans
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business
2.9.3 Lonza Organoid Biobank Product and Solutions
2.9.4 Lonza Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lonza Recent Developments and Future Plans
2.10 Prellis Biologics
2.10.1 Prellis Biologics Details
2.10.2 Prellis Biologics Major Business
2.10.3 Prellis Biologics Organoid Biobank Product and Solutions
2.10.4 Prellis Biologics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Prellis Biologics Recent Developments and Future Plans
2.11 Amsbio
2.11.1 Amsbio Details
2.11.2 Amsbio Major Business
2.11.3 Amsbio Organoid Biobank Product and Solutions
2.11.4 Amsbio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Amsbio Recent Developments and Future Plans
2.12 Cellesce
2.12.1 Cellesce Details
2.12.2 Cellesce Major Business
2.12.3 Cellesce Organoid Biobank Product and Solutions
2.12.4 Cellesce Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cellesce Recent Developments and Future Plans
2.13 DefiniGEN
2.13.1 DefiniGEN Details
2.13.2 DefiniGEN Major Business
2.13.3 DefiniGEN Organoid Biobank Product and Solutions
2.13.4 DefiniGEN Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 DefiniGEN Recent Developments and Future Plans
2.14 3Dnamics Inc.
2.14.1 3Dnamics Inc. Details
2.14.2 3Dnamics Inc. Major Business
2.14.3 3Dnamics Inc. Organoid Biobank Product and Solutions
2.14.4 3Dnamics Inc. Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 3Dnamics Inc. Recent Developments and Future Plans
2.15 Organoid Therapeutics
2.15.1 Organoid Therapeutics Details
2.15.2 Organoid Therapeutics Major Business
2.15.3 Organoid Therapeutics Organoid Biobank Product and Solutions
2.15.4 Organoid Therapeutics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Organoid Therapeutics Recent Developments and Future Plans
2.16 InSphero
2.16.1 InSphero Details
2.16.2 InSphero Major Business
2.16.3 InSphero Organoid Biobank Product and Solutions
2.16.4 InSphero Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 InSphero Recent Developments and Future Plans
2.17 AIVITA Biomedical
2.17.1 AIVITA Biomedical Details
2.17.2 AIVITA Biomedical Major Business
2.17.3 AIVITA Biomedical Organoid Biobank Product and Solutions
2.17.4 AIVITA Biomedical Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 AIVITA Biomedical Recent Developments and Future Plans
2.18 JangoBio
2.18.1 JangoBio Details
2.18.2 JangoBio Major Business
2.18.3 JangoBio Organoid Biobank Product and Solutions
2.18.4 JangoBio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 JangoBio Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Organoid Biobank Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Organoid Biobank by Company Revenue
3.2.2 Top 3 Organoid Biobank Players Market Share in 2022
3.2.3 Top 6 Organoid Biobank Players Market Share in 2022
3.3 Organoid Biobank Market: Overall Company Footprint Analysis
3.3.1 Organoid Biobank Market: Region Footprint
3.3.2 Organoid Biobank Market: Company Product Type Footprint
3.3.3 Organoid Biobank Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Organoid Biobank Consumption Value and Market Share by Type (2018-2023)
4.2 Global Organoid Biobank Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Organoid Biobank Consumption Value Market Share by Application (2018-2023)
5.2 Global Organoid Biobank Market Forecast by Application (2024-2029)
6 North America
6.1 North America Organoid Biobank Consumption Value by Type (2018-2029)
6.2 North America Organoid Biobank Consumption Value by Application (2018-2029)
6.3 North America Organoid Biobank Market Size by Country
6.3.1 North America Organoid Biobank Consumption Value by Country (2018-2029)
6.3.2 United States Organoid Biobank Market Size and Forecast (2018-2029)
6.3.3 Canada Organoid Biobank Market Size and Forecast (2018-2029)
6.3.4 Mexico Organoid Biobank Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Organoid Biobank Consumption Value by Type (2018-2029)
7.2 Europe Organoid Biobank Consumption Value by Application (2018-2029)
7.3 Europe Organoid Biobank Market Size by Country
7.3.1 Europe Organoid Biobank Consumption Value by Country (2018-2029)
7.3.2 Germany Organoid Biobank Market Size and Forecast (2018-2029)
7.3.3 France Organoid Biobank Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Organoid Biobank Market Size and Forecast (2018-2029)
7.3.5 Russia Organoid Biobank Market Size and Forecast (2018-2029)
7.3.6 Italy Organoid Biobank Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Organoid Biobank Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Organoid Biobank Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Organoid Biobank Market Size by Region
8.3.1 Asia-Pacific Organoid Biobank Consumption Value by Region (2018-2029)
8.3.2 China Organoid Biobank Market Size and Forecast (2018-2029)
8.3.3 Japan Organoid Biobank Market Size and Forecast (2018-2029)
8.3.4 South Korea Organoid Biobank Market Size and Forecast (2018-2029)
8.3.5 India Organoid Biobank Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Organoid Biobank Market Size and Forecast (2018-2029)
8.3.7 Australia Organoid Biobank Market Size and Forecast (2018-2029)
9 South America
9.1 South America Organoid Biobank Consumption Value by Type (2018-2029)
9.2 South America Organoid Biobank Consumption Value by Application (2018-2029)
9.3 South America Organoid Biobank Market Size by Country
9.3.1 South America Organoid Biobank Consumption Value by Country (2018-2029)
9.3.2 Brazil Organoid Biobank Market Size and Forecast (2018-2029)
9.3.3 Argentina Organoid Biobank Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Organoid Biobank Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Organoid Biobank Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Organoid Biobank Market Size by Country
10.3.1 Middle East & Africa Organoid Biobank Consumption Value by Country (2018-2029)
10.3.2 Turkey Organoid Biobank Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Organoid Biobank Market Size and Forecast (2018-2029)
10.3.4 UAE Organoid Biobank Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Organoid Biobank Market Drivers
11.2 Organoid Biobank Market Restraints
11.3 Organoid Biobank Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Organoid Biobank Industry Chain
12.2 Organoid Biobank Upstream Analysis
12.3 Organoid Biobank Midstream Analysis
12.4 Organoid Biobank Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Organoid Biobank Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Organoid Biobank Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Organoid Biobank Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Organoid Biobank Consumption Value by Region (2024-2029) & (USD Million)
Table 5. FRANKFURT CANCER INSTITUTE Company Information, Head Office, and Major Competitors
Table 6. FRANKFURT CANCER INSTITUTE Major Business
Table 7. FRANKFURT CANCER INSTITUTE Organoid Biobank Product and Solutions
Table 8. FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. FRANKFURT CANCER INSTITUTE Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Organoid Biobank Product and Solutions
Table 13. Merck Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck Recent Developments and Future Plans
Table 15. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 16. Crown Bioscience Major Business
Table 17. Crown Bioscience Organoid Biobank Product and Solutions
Table 18. Crown Bioscience Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Crown Bioscience Recent Developments and Future Plans
Table 20. HUB Organoids Company Information, Head Office, and Major Competitors
Table 21. HUB Organoids Major Business
Table 22. HUB Organoids Organoid Biobank Product and Solutions
Table 23. HUB Organoids Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. HUB Organoids Recent Developments and Future Plans
Table 25. Cancer Research UK Convergence Science Centre Company Information, Head Office, and Major Competitors
Table 26. Cancer Research UK Convergence Science Centre Major Business
Table 27. Cancer Research UK Convergence Science Centre Organoid Biobank Product and Solutions
Table 28. Cancer Research UK Convergence Science Centre Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Cancer Research UK Convergence Science Centre Recent Developments and Future Plans
Table 30. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 31. Thermo Fisher Scientific Major Business
Table 32. Thermo Fisher Scientific Organoid Biobank Product and Solutions
Table 33. Thermo Fisher Scientific Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Thermo Fisher Scientific Recent Developments and Future Plans
Table 35. Corning Company Information, Head Office, and Major Competitors
Table 36. Corning Major Business
Table 37. Corning Organoid Biobank Product and Solutions
Table 38. Corning Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Corning Recent Developments and Future Plans
Table 40. STEMCELL Technologies Company Information, Head Office, and Major Competitors
Table 41. STEMCELL Technologies Major Business
Table 42. STEMCELL Technologies Organoid Biobank Product and Solutions
Table 43. STEMCELL Technologies Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. STEMCELL Technologies Recent Developments and Future Plans
Table 45. Lonza Company Information, Head Office, and Major Competitors
Table 46. Lonza Major Business
Table 47. Lonza Organoid Biobank Product and Solutions
Table 48. Lonza Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lonza Recent Developments and Future Plans
Table 50. Prellis Biologics Company Information, Head Office, and Major Competitors
Table 51. Prellis Biologics Major Business
Table 52. Prellis Biologics Organoid Biobank Product and Solutions
Table 53. Prellis Biologics Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Prellis Biologics Recent Developments and Future Plans
Table 55. Amsbio Company Information, Head Office, and Major Competitors
Table 56. Amsbio Major Business
Table 57. Amsbio Organoid Biobank Product and Solutions
Table 58. Amsbio Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Amsbio Recent Developments and Future Plans
Table 60. Cellesce Company Information, Head Office, and Major Competitors
Table 61. Cellesce Major Business
Table 62. Cellesce Organoid Biobank Product and Solutions
Table 63. Cellesce Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Cellesce Recent Developments and Future Plans
Table 65. DefiniGEN Company Information, Head Office, and Major Competitors
Table 66. DefiniGEN Major Business
Table 67. DefiniGEN Organoid Biobank Product and Solutions
Table 68. DefiniGEN Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. DefiniGEN Recent Developments and Future Plans
Table 70. 3Dnamics Inc. Company Information, Head Office, and Major Competitors
Table 71. 3Dnamics Inc. Major Business
Table 72. 3Dnamics Inc. Organoid Biobank Product and Solutions
Table 73. 3Dnamics Inc. Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. 3Dnamics Inc. Recent Developments and Future Plans
Table 75. Organoid Therapeutics Company Information, Head Office, and Major Competitors
Table 76. Organoid Therapeutics Major Business
Table 77. Organoid Therapeutics Organoid Biobank Product and Solutions
Table 78. Organoid Therapeutics Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Organoid Therapeutics Recent Developments and Future Plans
Table 80. InSphero Company Information, Head Office, and Major Competitors
Table 81. InSphero Major Business
Table 82. InSphero Organoid Biobank Product and Solutions
Table 83. InSphero Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. InSphero Recent Developments and Future Plans
Table 85. AIVITA Biomedical Company Information, Head Office, and Major Competitors
Table 86. AIVITA Biomedical Major Business
Table 87. AIVITA Biomedical Organoid Biobank Product and Solutions
Table 88. AIVITA Biomedical Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AIVITA Biomedical Recent Developments and Future Plans
Table 90. JangoBio Company Information, Head Office, and Major Competitors
Table 91. JangoBio Major Business
Table 92. JangoBio Organoid Biobank Product and Solutions
Table 93. JangoBio Organoid Biobank Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. JangoBio Recent Developments and Future Plans
Table 95. Global Organoid Biobank Revenue (USD Million) by Players (2018-2023)
Table 96. Global Organoid Biobank Revenue Share by Players (2018-2023)
Table 97. Breakdown of Organoid Biobank by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Organoid Biobank, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Organoid Biobank Players
Table 100. Organoid Biobank Market: Company Product Type Footprint
Table 101. Organoid Biobank Market: Company Product Application Footprint
Table 102. Organoid Biobank New Market Entrants and Barriers to Market Entry
Table 103. Organoid Biobank Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Organoid Biobank Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Organoid Biobank Consumption Value Share by Type (2018-2023)
Table 106. Global Organoid Biobank Consumption Value Forecast by Type (2024-2029)
Table 107. Global Organoid Biobank Consumption Value by Application (2018-2023)
Table 108. Global Organoid Biobank Consumption Value Forecast by Application (2024-2029)
Table 109. North America Organoid Biobank Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Organoid Biobank Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Organoid Biobank Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Organoid Biobank Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Organoid Biobank Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Organoid Biobank Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Organoid Biobank Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Organoid Biobank Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Organoid Biobank Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Organoid Biobank Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Organoid Biobank Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Organoid Biobank Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Organoid Biobank Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Organoid Biobank Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Organoid Biobank Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Organoid Biobank Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Organoid Biobank Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Organoid Biobank Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Organoid Biobank Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Organoid Biobank Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Organoid Biobank Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Organoid Biobank Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Organoid Biobank Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Organoid Biobank Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Organoid Biobank Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Organoid Biobank Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Organoid Biobank Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Organoid Biobank Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Organoid Biobank Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Organoid Biobank Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Organoid Biobank Raw Material
Table 140. Key Suppliers of Organoid Biobank Raw Materials
List of Figures
Figure 1. Organoid Biobank Picture
Figure 2. Global Organoid Biobank Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Organoid Biobank Consumption Value Market Share by Type in 2022
Figure 4. Tissue Derived Organoids
Figure 5. Pluripotent Stem Cell-derived Organoids
Figure 6. Global Organoid Biobank Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Organoid Biobank Consumption Value Market Share by Application in 2022
Figure 8. Biopharmaceutical Companies Picture
Figure 9. Contract Research Organizations Picture
Figure 10. Academics and Research Institutes Picture
Figure 11. Global Organoid Biobank Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Organoid Biobank Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Organoid Biobank Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Organoid Biobank Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Organoid Biobank Consumption Value Market Share by Region in 2022
Figure 16. North America Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Organoid Biobank Revenue Share by Players in 2022
Figure 22. Organoid Biobank Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Organoid Biobank Market Share in 2022
Figure 24. Global Top 6 Players Organoid Biobank Market Share in 2022
Figure 25. Global Organoid Biobank Consumption Value Share by Type (2018-2023)
Figure 26. Global Organoid Biobank Market Share Forecast by Type (2024-2029)
Figure 27. Global Organoid Biobank Consumption Value Share by Application (2018-2023)
Figure 28. Global Organoid Biobank Market Share Forecast by Application (2024-2029)
Figure 29. North America Organoid Biobank Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Organoid Biobank Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Organoid Biobank Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Organoid Biobank Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Organoid Biobank Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Organoid Biobank Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 39. France Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Organoid Biobank Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Organoid Biobank Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Organoid Biobank Consumption Value Market Share by Region (2018-2029)
Figure 46. China Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 49. India Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Organoid Biobank Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Organoid Biobank Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Organoid Biobank Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Organoid Biobank Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Organoid Biobank Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Organoid Biobank Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 63. Organoid Biobank Market Drivers
Figure 64. Organoid Biobank Market Restraints
Figure 65. Organoid Biobank Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Organoid Biobank in 2022
Figure 68. Manufacturing Process Analysis of Organoid Biobank
Figure 69. Organoid Biobank Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
